COMMUNIQUÉS West-GlobeNewswire
-
NewGen Provides Recap of Strategic Progress as Diversification Fuels Success, Positions Company for Breakout Year
24/02/2026 -
Dentsply Sirona and Burkhart Dental Supply Announce Expanded Distribution Partnership to Include Dental Technology Equipment
24/02/2026 -
Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer
24/02/2026 -
Actuate Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
24/02/2026 -
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
24/02/2026 -
ENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal Camera
24/02/2026 -
OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers
24/02/2026 -
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
24/02/2026 -
Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)
24/02/2026 -
BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
24/02/2026 -
Communiqué de presse : Dupixent de Sanofi et Regeneron est approuvé aux États-Unis comme le premier et le seul médicament pour la rhinosinusite fongique allergique
24/02/2026 -
EmblemHealth and Mae Health Announce Partnership to Give Members Access to Pregnancy and Postpartum Digital Health Support and Community-Based Doulas
24/02/2026 -
Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement
24/02/2026 -
Disc Medicine to Participate in Upcoming Investor Conferences
24/02/2026 -
Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference
24/02/2026 -
Oncolytics Biotech® to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer
24/02/2026 -
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research
24/02/2026 -
Human Continuum Appoints Dr. Michael Milligan, MD, MBA, as its Chief Medical Officer to Oversee Innovative Applications for Next-Generation Extracellular Vesicle Therapeutics
24/02/2026 -
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals
24/02/2026
Pages